Live Breaking News & Updates on Insulet Omnipod|Page 10
Stay updated with breaking news from Insulet omnipod. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leerink Partnrs reissued their outperform rating on shares of Insulet (NASDAQ:PODD – Free Report) in a research note published on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Insulet’s Q3 2023 earnings at $0.44 EPS, Q4 2023 earnings at $0.68 EPS, Q1 2024 earnings at $0.48 EPS, Q2 2024 earnings at $0.69 EPS, Q3 […] ....
Insulet Co. (NASDAQ:PODD – Get Free Report) saw a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 3,570,000 shares, a growth of 24.0% from the September 15th total of 2,880,000 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is […] ....
EFG Asset Management North America Corp. raised its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 14.7% in the second quarter, HoldingsChannel.com reports. The firm owned 15,590 shares of the medical instruments supplier’s stock after purchasing an additional 1,995 shares during the quarter. EFG Asset Management North America Corp.’s holdings in Insulet were worth […] ....